
In-Vitro Diagnostics Industry Research Report 2024
Description
In-Vitro Diagnostics Industry Research Report 2024
Summary
In-Vitro Diagnostics (IVD) is the test for detecting diseases. In this report, we counted In-Vitro Diagnostics reagent.
According to APO Research, The global In-Vitro Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for In-Vitro Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for In-Vitro Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for In-Vitro Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of In-Vitro Diagnostics include Roche, Siemens, Abbott, Danaher, Thermo Fisher, BioMerieux, Bio-Rad, BD and JNJ, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for In-Vitro Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In-Vitro Diagnostics.The In-Vitro Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global In-Vitro Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
RocheSiemensAbbottDanaherThermo FisherBioMerieuxBio-RadBDJNJSysmexKHBDaAn GeneLeadmanBioSinoBSBEMaccuraIn-Vitro Diagnostics segment by Type
Tissue DiagnosticsProfessional DiagnosticMolecular DiagnosticDiabetes MonitoringOtherIn-Vitro Diagnostics Segment by Application
DiabetesInfectious DiseasesOncologyCardiologyHIVOtherIn-Vitro Diagnostics Segment by Region
North AmericaUnited StatesCanadaEuropeGermanyFranceUKItalyRussiaNordic CountriesRest of EuropeAsia-PacificChinaJapanSouth KoreaSoutheast AsiaIndiaAustraliaRest of AsiaLatin AmericaMexicoBrazilRest of Latin AmericaMiddle East & AfricaTurkeySaudi ArabiaUAERest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In-Vitro Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of In-Vitro Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In-Vitro Diagnostics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of In-Vitro Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Table of Contents
130 Pages
- 1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
- 2 Market Overview
- 2.1 Product Definition
- 2.2 In-Vitro Diagnostics by Type
- 2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
- 2.2.2 Tissue Diagnostics
- 2.2.3 Professional Diagnostic
- 2.2.4 Molecular Diagnostic
- 2.2.5 Diabetes Monitoring
- 2.2.6 Other
- 2.3 In-Vitro Diagnostics by Application
- 2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
- 2.3.2 Diabetes
- 2.3.3 Infectious Diseases
- 2.3.4 Oncology
- 2.3.5 Cardiology
- 2.3.6 HIV
- 2.3.7 Other
- 2.4 Assumptions and Limitations
- 3 In-Vitro Diagnostics Breakdown Data by Type
- 3.1 Global In-Vitro Diagnostics Historic Market Size by Type (2019-2024)
- 3.2 Global In-Vitro Diagnostics Forecasted Market Size by Type (2025-2030)
- 4 In-Vitro Diagnostics Breakdown Data by Application
- 4.1 Global In-Vitro Diagnostics Historic Market Size by Application (2019-2024)
- 4.2 Global In-Vitro Diagnostics Forecasted Market Size by Application (2019-2024)
- 5 Global Growth Trends
- 5.1 Global In-Vitro Diagnostics Market Perspective (2019-2030)
- 5.2 Global In-Vitro Diagnostics Growth Trends by Region
- 5.2.1 Global In-Vitro Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
- 5.2.2 In-Vitro Diagnostics Historic Market Size by Region (2019-2024)
- 5.2.3 In-Vitro Diagnostics Forecasted Market Size by Region (2025-2030)
- 5.3 In-Vitro Diagnostics Market Dynamics
- 5.3.1 In-Vitro Diagnostics Industry Trends
- 5.3.2 In-Vitro Diagnostics Market Drivers
- 5.3.3 In-Vitro Diagnostics Market Challenges
- 5.3.4 In-Vitro Diagnostics Market Restraints
- 6 Market Competitive Landscape by Players
- 6.1 Global Top In-Vitro Diagnostics Players by Revenue
- 6.1.1 Global Top In-Vitro Diagnostics Players by Revenue (2019-2024)
- 6.1.2 Global In-Vitro Diagnostics Revenue Market Share by Players (2019-2024)
- 6.2 Global In-Vitro Diagnostics Industry Players Ranking, 2022 VS 2023 VS 2024
- 6.3 Global Key Players of In-Vitro Diagnostics Head office and Area Served
- 6.4 Global In-Vitro Diagnostics Players, Product Type & Application
- 6.5 Global In-Vitro Diagnostics Players, Date of Enter into This Industry
- 6.6 Global In-Vitro Diagnostics Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
- 7 North America
- 7.1 North America In-Vitro Diagnostics Market Size (2019-2030)
- 7.2 North America In-Vitro Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 7.3 North America In-Vitro Diagnostics Market Size by Country (2019-2024)
- 7.4 North America In-Vitro Diagnostics Market Size by Country (2025-2030)
- 7.5 United States
- 7.6 Canada
- 8 Europe
- 8.1 Europe In-Vitro Diagnostics Market Size (2019-2030)
- 8.2 Europe In-Vitro Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 8.3 Europe In-Vitro Diagnostics Market Size by Country (2019-2024)
- 8.4 Europe In-Vitro Diagnostics Market Size by Country (2025-2030)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Russia
- 8.10 Nordic Countries
- 9 Asia-Pacific
- 9.1 Asia-Pacific In-Vitro Diagnostics Market Size (2019-2030)
- 9.2 Asia-Pacific In-Vitro Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 9.3 Asia-Pacific In-Vitro Diagnostics Market Size by Country (2019-2024)
- 9.4 Asia-Pacific In-Vitro Diagnostics Market Size by Country (2025-2030)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 Southeast Asia
- 9.9 India
- 9.10 Australia
- 10 Latin America
- 10.1 Latin America In-Vitro Diagnostics Market Size (2019-2030)
- 10.2 Latin America In-Vitro Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 10.3 Latin America In-Vitro Diagnostics Market Size by Country (2019-2024)
- 10.4 Latin America In-Vitro Diagnostics Market Size by Country (2025-2030)
- 10.5 Mexico
- 10.6 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa In-Vitro Diagnostics Market Size (2019-2030)
- 11.2 Middle East & Africa In-Vitro Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 11.3 Middle East & Africa In-Vitro Diagnostics Market Size by Country (2019-2024)
- 11.4 Middle East & Africa In-Vitro Diagnostics Market Size by Country (2025-2030)
- 11.5 Turkey
- 11.6 Saudi Arabia
- 11.7 UAE
- 12 Players Profiled
- 12.1 Roche
- 12.1.1 Roche Company Information
- 12.1.2 Roche Business Overview
- 12.1.3 Roche Revenue in In-Vitro Diagnostics Business (2019-2024)
- 12.1.4 Roche In-Vitro Diagnostics Product Portfolio
- 12.1.5 Roche Recent Developments
- 12.2 Siemens
- 12.2.1 Siemens Company Information
- 12.2.2 Siemens Business Overview
- 12.2.3 Siemens Revenue in In-Vitro Diagnostics Business (2019-2024)
- 12.2.4 Siemens In-Vitro Diagnostics Product Portfolio
- 12.2.5 Siemens Recent Developments
- 12.3 Abbott
- 12.3.1 Abbott Company Information
- 12.3.2 Abbott Business Overview
- 12.3.3 Abbott Revenue in In-Vitro Diagnostics Business (2019-2024)
- 12.3.4 Abbott In-Vitro Diagnostics Product Portfolio
- 12.3.5 Abbott Recent Developments
- 12.4 Danaher
- 12.4.1 Danaher Company Information
- 12.4.2 Danaher Business Overview
- 12.4.3 Danaher Revenue in In-Vitro Diagnostics Business (2019-2024)
- 12.4.4 Danaher In-Vitro Diagnostics Product Portfolio
- 12.4.5 Danaher Recent Developments
- 12.5 Thermo Fisher
- 12.5.1 Thermo Fisher Company Information
- 12.5.2 Thermo Fisher Business Overview
- 12.5.3 Thermo Fisher Revenue in In-Vitro Diagnostics Business (2019-2024)
- 12.5.4 Thermo Fisher In-Vitro Diagnostics Product Portfolio
- 12.5.5 Thermo Fisher Recent Developments
- 12.6 BioMerieux
- 12.6.1 BioMerieux Company Information
- 12.6.2 BioMerieux Business Overview
- 12.6.3 BioMerieux Revenue in In-Vitro Diagnostics Business (2019-2024)
- 12.6.4 BioMerieux In-Vitro Diagnostics Product Portfolio
- 12.6.5 BioMerieux Recent Developments
- 12.7 Bio-Rad
- 12.7.1 Bio-Rad Company Information
- 12.7.2 Bio-Rad Business Overview
- 12.7.3 Bio-Rad Revenue in In-Vitro Diagnostics Business (2019-2024)
- 12.7.4 Bio-Rad In-Vitro Diagnostics Product Portfolio
- 12.7.5 Bio-Rad Recent Developments
- 12.8 BD
- 12.8.1 BD Company Information
- 12.8.2 BD Business Overview
- 12.8.3 BD Revenue in In-Vitro Diagnostics Business (2019-2024)
- 12.8.4 BD In-Vitro Diagnostics Product Portfolio
- 12.8.5 BD Recent Developments
- 12.9 JNJ
- 12.9.1 JNJ Company Information
- 12.9.2 JNJ Business Overview
- 12.9.3 JNJ Revenue in In-Vitro Diagnostics Business (2019-2024)
- 12.9.4 JNJ In-Vitro Diagnostics Product Portfolio
- 12.9.5 JNJ Recent Developments
- 12.10 Sysmex
- 12.10.1 Sysmex Company Information
- 12.10.2 Sysmex Business Overview
- 12.10.3 Sysmex Revenue in In-Vitro Diagnostics Business (2019-2024)
- 12.10.4 Sysmex In-Vitro Diagnostics Product Portfolio
- 12.10.5 Sysmex Recent Developments
- 12.11 KHB
- 12.11.1 KHB Company Information
- 12.11.2 KHB Business Overview
- 12.11.3 KHB Revenue in In-Vitro Diagnostics Business (2019-2024)
- 12.11.4 KHB In-Vitro Diagnostics Product Portfolio
- 12.11.5 KHB Recent Developments
- 12.12 DaAn Gene
- 12.12.1 DaAn Gene Company Information
- 12.12.2 DaAn Gene Business Overview
- 12.12.3 DaAn Gene Revenue in In-Vitro Diagnostics Business (2019-2024)
- 12.12.4 DaAn Gene In-Vitro Diagnostics Product Portfolio
- 12.12.5 DaAn Gene Recent Developments
- 12.13 Leadman
- 12.13.1 Leadman Company Information
- 12.13.2 Leadman Business Overview
- 12.13.3 Leadman Revenue in In-Vitro Diagnostics Business (2019-2024)
- 12.13.4 Leadman In-Vitro Diagnostics Product Portfolio
- 12.13.5 Leadman Recent Developments
- 12.14 BioSino
- 12.14.1 BioSino Company Information
- 12.14.2 BioSino Business Overview
- 12.14.3 BioSino Revenue in In-Vitro Diagnostics Business (2019-2024)
- 12.14.4 BioSino In-Vitro Diagnostics Product Portfolio
- 12.14.5 BioSino Recent Developments
- 12.15 BSBE
- 12.15.1 BSBE Company Information
- 12.15.2 BSBE Business Overview
- 12.15.3 BSBE Revenue in In-Vitro Diagnostics Business (2019-2024)
- 12.15.4 BSBE In-Vitro Diagnostics Product Portfolio
- 12.15.5 BSBE Recent Developments
- 12.16 Maccura
- 12.16.1 Maccura Company Information
- 12.16.2 Maccura Business Overview
- 12.16.3 Maccura Revenue in In-Vitro Diagnostics Business (2019-2024)
- 12.16.4 Maccura In-Vitro Diagnostics Product Portfolio
- 12.16.5 Maccura Recent Developments
- 13 Report Conclusion
- 14 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.